About [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid
[1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid (PubChem CID 135388926) has the molecular formula C25H25BrClN7O4
and a molecular weight of 602.88 g/mol. Its IUPAC name is [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid.
Molecular Properties
| Compound Name | [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid |
| PubChem CID | 135388926 |
| Molecular Formula | C25H25BrClN7O4 |
| Molecular Weight | 602.88 g/mol |
| Exact Mass | 601.08 |
| IUPAC Name | [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid |
| SMILES | COc1ccc(Cn2nc(Oc3c(Cl)cncc3Br)c3ncc(N4CCC(C)(NC(=O)O)CC4)nc32)cc1 |
| InChI | InChI=1S/C25H25BrClN7O4/c1-25(31-24(35)36)7-9-33(10-8-25)19-13-29-20-22(30-19)34(14-15-3-5-16(37-2)6-4-15)32-23(20)38-21-17(26)11-28-12-18(21)27/h3-6,11-13,31H,7-10,14H2,1-2H3,(H,35,36) |
| InChIKey | RIORSPGMXBNJPC-UHFFFAOYSA-N |
| XLogP | 5.11 |
| TPSA | 127.52 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 602.88 |
| LogP ≤ 5 | 5.11 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Analyze [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The IUPAC name of [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid (CID 135388926) is [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid.
What is the SMILES notation for [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The canonical SMILES for [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid is COc1ccc(Cn2nc(Oc3c(Cl)cncc3Br)c3ncc(N4CCC(C)(NC(=O)O)CC4)nc32)cc1.
What is the InChIKey of [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
The InChIKey is RIORSPGMXBNJPC-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H25BrClN7O4/c1-25(31-24(35)36)7-9-33(10-8-25)19-13-29-20-22(30-19)34(14-15-3-5-16(37-2)6-4-15)32-23(20)38-21-17(26)11-28-12-18(21)27/h3-6,11-13,31H,7-10,14H2,1-2H3,(H,35,36).
What are the key properties of [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid?
[1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid has a molecular weight of 602.88 g/mol, XLogP of 5.11, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[3-[(3-bromo-5-chloro-4-pyridinyl)oxy]-1-[(4-methoxyphenyl)methyl]pyrazolo[3,4-b]pyrazin-6-yl]-4-methylpiperidin-4-yl]carbamic acid is sourced from PubChem (CID 135388926), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).